Skip to content
Saturday, November 14, 2026
Advanced Link UK

Zimbabwe Declines ‘One-Sided’ US Healthcare Assistance Deal Because of Data Fears

Health funding image
The offered US financial assistance would have supported initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a significant American healthcare agreement worth 367 million US dollars (£272m) spanning five years due to the United States' request for confidential data.

This move came to light after a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".

A government spokesperson later clarified that the United States was demanding access to biological samples for scientific study and profit while was not willing to guarantee the benefits from any future vaccines.

"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has appealed for more talks to reach a agreement suitable to all parties so the country's vital HIV programme can be sustained.

Broader Implications

This development follows a similar case in Kenya, where a court blocked a related deal with the US following legal challenges were raised about the security of Kenyans' medical information.

Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen aid for the American government, but Trump stated its spending was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and responsibility.

According to statements, Sixteen nations in Africa have so far agreed to similar agreements, constituting more than $18.3bn in committed funds.

Details of the Rejected Agreement

This assistance for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this partnership could have provided significant advantages for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through American-funded initiatives," the Ambassador said.

However, government spokesperson Nick Mangwana argued the arrangement was "unfair".

"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding assurance of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," he stated.

"In essence, our nation would provide the basic resources for medical research with no assurance that the final treatments would be accessible to our people should a future disease outbreak arise."

National Interest and Global Health

He also said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining frameworks already set up via the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to manage potential pandemics.

"This mechanism is designed to guarantee that when a nation contributes its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."

The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.

"We are open to ongoing dialogue with our US partners on how subsequent collaboration could be arranged in a manner that honours the independence and dignity of both nations."

Health Experts Response

A leading public health body expressed it understood the government's concerns, but urged that negotiations need to persist given that a large portion of the country's HIV programmes depended on external financing.

"Where specific concerns arise, such as those involving data governance or implementation frameworks, these can frequently be resolved via technical clarification and mutually agreed protections," the group said.

This impasse underscores the continuing debate between receiving much-needed international aid and protecting a country's data in an increasingly interconnected world.

JM
The writer

James Mcguire

Elena is a digital strategist with over a decade of experience in SEO and content marketing, helping businesses optimize their online presence.

Advanced Link UK

Type to search articles.